Stay updated on Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new record-history entry dated November 18, 2026 indicates that the clinical trial’s study status was updated. The site revision also advances to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-19T11:40:00.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The site's footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-10-29T10:53:29.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A notice about NIH website terminology changes and transition updates was added to the page.
    Difference
    0.0%
    Check dated 2026-10-22T09:49:52.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-15T13:11:29.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-08T14:48:29.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    A new version 1052 posted on 2026-10-01 updates the study's Contacts/Locations and Study Status. The prior version dated 2026-08-04 was removed.
    Difference
    0.0%
    Check dated 2026-10-01T14:55:14.000Z thumbnail image

Stay in the know with updates to Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.